These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
774 related articles for article (PubMed ID: 29633510)
1. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12. Xue D; Lu H; Xu HY; Zhou CX; He XZ J Cell Mol Med; 2018 Jun; 22(6):3223-3237. PubMed ID: 29633510 [TBL] [Abstract][Full Text] [Related]
2. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells. Bai T; Liu Y; Li B IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543 [TBL] [Abstract][Full Text] [Related]
3. Exosomal circRNA Scm-like with four malignant brain tumor domains 2 (circ-SFMBT2) enhances the docetaxel resistance of prostate cancer via the microRNA-136-5p/tribbles homolog 1 pathway. Tan X; Song X; Fan B; Li M; Zhang A; Pei L Anticancer Drugs; 2022 Oct; 33(9):871-882. PubMed ID: 36136987 [TBL] [Abstract][Full Text] [Related]
4. MiR-129-5p promotes docetaxel resistance in prostate cancer by down-regulating CAMK2N1 expression. Wu C; Miao C; Tang Q; Zhou X; Xi P; Chang P; Hua L; Ni H J Cell Mol Med; 2020 Feb; 24(3):2098-2108. PubMed ID: 31876385 [TBL] [Abstract][Full Text] [Related]
5. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells. Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561 [TBL] [Abstract][Full Text] [Related]
6. Circ_0003998 Regulates the Progression and Docetaxel Sensitivity of DTX-Resistant Non-Small Cell Lung Cancer Cells by the miR-136-5p/CORO1C Axis. Zhang W; Song C; Ren X Technol Cancer Res Treat; 2021; 20():1533033821990040. PubMed ID: 33511909 [TBL] [Abstract][Full Text] [Related]
7. LncRNA LINC00184 promotes docetaxel resistance and immune escape via miR-105-5p/PD-L1 axis in prostate cancer. Zhang W; Xin J; Lai J; Zhang W Immunobiology; 2022 Jan; 227(1):152163. PubMed ID: 34896914 [TBL] [Abstract][Full Text] [Related]
8. Silencing of LINC01963 enhances the chemosensitivity of prostate cancer cells to docetaxel by targeting the miR-216b-5p/TrkB axis. Xing Z; Li S; Xing J; Yu G; Wang G; Liu Z Lab Invest; 2022 Jun; 102(6):602-612. PubMed ID: 35152275 [TBL] [Abstract][Full Text] [Related]
9. LncRNA NEAT1 promotes docetaxel resistance in prostate cancer by regulating ACSL4 via sponging miR-34a-5p and miR-204-5p. Jiang X; Guo S; Zhang Y; Zhao Y; Li X; Jia Y; Xu Y; Ma B Cell Signal; 2020 Jan; 65():109422. PubMed ID: 31672604 [TBL] [Abstract][Full Text] [Related]
10. MALAT1 knockdown inhibits prostate cancer progression by regulating miR-140/BIRC6 axis. Hao T; Wang Z; Yang J; Zhang Y; Shang Y; Sun J Biomed Pharmacother; 2020 Mar; 123():109666. PubMed ID: 31935634 [TBL] [Abstract][Full Text] [Related]
11. Exosomal Circ-XIAP Promotes Docetaxel Resistance in Prostate Cancer by Regulating miR-1182/TPD52 Axis. Zhang H; Li M; Zhang J; Shen Y; Gui Q Drug Des Devel Ther; 2021; 15():1835-1849. PubMed ID: 33976535 [TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA PCA3 regulates prostate cancer through sponging miR-218-5p and modulating high mobility group box 1. Zhang G; He X; Ren C; Lin J; Wang Q J Cell Physiol; 2019 Aug; 234(8):13097-13109. PubMed ID: 30569456 [TBL] [Abstract][Full Text] [Related]
13. LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p/QKI-5 axis. Wu M; Huang Y; Chen T; Wang W; Yang S; Ye Z; Xi X J Cell Mol Med; 2019 Jan; 23(1):29-38. PubMed ID: 30565858 [TBL] [Abstract][Full Text] [Related]
14. LncRNA MALAT1 accelerates non-small cell lung cancer progression via regulating miR-185-5p/MDM4 axis. Wang D; Zhang S; Zhao M; Chen F Cancer Med; 2020 Dec; 9(23):9138-9149. PubMed ID: 33146951 [TBL] [Abstract][Full Text] [Related]
15. LncRNA AFAP1-AS1 modulates the sensitivity of paclitaxel-resistant prostate cancer cells to paclitaxel via miR-195-5p/FKBP1A axis. Leng W; Liu Q; Zhang S; Sun D; Guo Y Cancer Biol Ther; 2020 Nov; 21(11):1072-1080. PubMed ID: 33138677 [TBL] [Abstract][Full Text] [Related]
16. LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axis. Cao Y; Zhang F; Wang H; Bi C; Cui J; Liu F; Pan H Mol Cell Biochem; 2021 Jan; 476(1):279-292. PubMed ID: 32965597 [TBL] [Abstract][Full Text] [Related]
17. The lncRNA OGFRP1/miR-149-5p/IL-6 axis regulates prostate cancer chemoresistance. Wang C; Ding T; Yang D; Zhang P; Hu X; Qin W; Zheng J Pathol Res Pract; 2021 Aug; 224():153535. PubMed ID: 34293716 [TBL] [Abstract][Full Text] [Related]
18. Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1. Li X; Han X; Wei P; Yang J; Sun J Cancer Biol Ther; 2020 May; 21(5):452-462. PubMed ID: 32089062 [TBL] [Abstract][Full Text] [Related]
19. [LncRNA RPL22P1-201 affects prostate cancer cell proliferation, cell cycle, and sensitivity to docetaxel by regulating miR-216b-5p expression]. Yang C; Xue JG Zhonghua Nan Ke Xue; 2023 Oct; 29(10):881-887. PubMed ID: 38639656 [TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA SOX2-OT Knockdown Inhibits Proliferation and Metastasis of Prostate Cancer Cells Through Modulating the miR-452-5p/HMGB3 Axis and Inactivating Wnt/β-Catenin Pathway. Song X; Wang H; Wu J; Sun Y Cancer Biother Radiopharm; 2020 Nov; 35(9):682-695. PubMed ID: 32407168 [No Abstract] [Full Text] [Related] [Next] [New Search]